文献速递胸部肿瘤放疗中枢神经肿瘤放疗姑息放疗与转移瘤

IV期小细胞肺癌的预防性颅脑照射:欧洲IASLC与ESTRO专家间的患者选择

Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.
PubMed 文献 · Radiother Oncol · 2019-01-31

该研究收集13名欧洲放射肿瘤与内科肿瘤专家对IV期小细胞肺癌预防性颅脑照射(PCI)的决策策略,采用客观共识方法分析。专家推荐对体能状态好、年轻且对化疗有反应的患者行PCI,对完全缓解的非老年体能好患者多数推荐PCI,对稳定疾病患者推荐比例低,老年体能好完全缓解患者多数推荐PCI,部分缓解患者未达共识。

要点

  • 多数专家推荐对非老年体能好且化疗至少部分缓解的IV期小细胞肺癌患者行PCI。
  • 对化疗后稳定疾病患者,放射肿瘤专家6/13(46%)、内科肿瘤专家3/13(23%)推荐PCI。
  • 老年体能好完全缓解患者多数推荐PCI(62%),部分缓解患者未达共识。

核心结论

  • 欧洲肺癌放射与内科肿瘤专家推荐对选定患者行PCI,主要限于体能好、非老年且对化疗有反应的患者。

研究设计与样本

  • 从欧洲放射肿瘤学会(ESTRO)和国际肺癌研究协会(IASLC)获得13名欧洲专家名单,收集IV期小细胞肺癌PCI决策策略并创建决策树,采用客观共识方法分析共识。

主要发现

  • 与推荐使用PCI相关的因素包括患者体能状态、年轻和对化疗反应良好。
  • 非老年体能好且化疗完全缓解患者,85%放射肿瘤专家和69%内科肿瘤专家推荐PCI。
  • 非老年体能好且化疗部分缓解患者,85%放射肿瘤专家和54%内科肿瘤专家推荐PCI。
  • 化疗后稳定疾病患者,6/13(46%)放射肿瘤专家和3/13(23%)内科肿瘤专家推荐PCI。
  • 老年体能好完全缓解患者,多数(62%)推荐PCI;部分缓解患者未达共识。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Due to conflicting results between major trials the role of prophylactic cranial irradiation (PCI) in stage IV small cell lung cancer (SCLC) is controversial. METHODS: We obtained a list of 13 European experts from both the European Society for Therapeutic Radiation Oncology (ESTRO) and the International Association for the Study of Lung Cancer (IASLC). The strategies in decision making for PCI in stage IV SCLC were collected. Decision trees were created representing these strategies. Analysis of consensus was performed with the objective consensus methodology. RESULTS: The factors associated with the recommendation for the use of PCI included the fitness of the patient, young age and good response to chemotherapy. PCI was recommended by the majority of experts for non-elderly fit patients who had at least a partial response (PR) to chemotherapy (for complete remission (CR) 85% of radiation oncologists and 69% of medical oncologists, for PR: 85% of radiation oncologists and 54% of medical oncologists). For patients with stable disease after chemotherapy, PCI was recommended by 6 out of 13 (46%) radiation oncologists and only 3 out of 13 medical oncologists (23%). For elderly fit patients with CR, a majority recommended PCI (62%) and no consensus was reached for patients with PR. CONCLUSION: European radiation and medical oncologists specializing in lung cancer recommend PCI in selected patients and restrict its use primarily to fit, non-elderly patients who responded to chemotherapy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Putora PM, Glatzer M, Belderbos J, et al. Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol. 2019. PMID: 30935574. doi:10.1016/j.radonc.2018.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。